"The retail investor has very little to do with this company. " False. Retail road kill is the raw material for one of BTX's two successful products: Hextend and T-shares.
Retail cannon fodder is what keeps the price above 14X sales--- thereby keeping this dog listed .
"They do certainly need to do a little more PR at least" Uh...what else besides PR DO they do??
Oh....get welfare checks to retiring out fellow travelers in the corspsicle cult.... and sell T-shares.
BTX does appear to be working hard toi get another couple of generics onto the mkt, which may, after 20 years, bring in revs almost equal to the cost of development.
Most of the recent pump was so that BTX could dilute & borrow/dilute another $100 million worth. Check the filings for an S3 around January.
As usual, retail cannon fodder got successfully sucked in.
And, as usual, all the "longs" here shut up as soon as they got out, leaving a new class of newbies to drop out or become cult members.
Yeah, If websites were revenues BTX might make it. As it is, the review of the new website on the tape seems to indicate that no, revenues are revenues, and selling T-stock is not a great business model---at least not for the retail road kill who keep falling for this thing.
" that company is letting the pricing go low to absorb all the hot cash" is total and compleat nonsense and boiler room smoke. Not long after BTX promised to sell $100mm in T-stock and bonds, it began pumping the price by any means possible to get the least dilution for insiders and cronies.
And, as usual, retail cannon fodder paid for it all.
" So far, one patient in 3 months." Uhuh. And it will remain so. As GERN started realising they were not going to get anywhere with Mikey's thinking, the first excuse they had was "Airbags work too well."
The entirety of the "good news" in the first trial was that nothing happened at all, and therefore nothing went wrong.
On that basis, double the dose and relocated the injection point superior on the axis---which only scored 71 on the CIRM scale for utility as anything other than a real-estate subsidy to BTX's landlords.
Whoa. I have never stated that BTX was all smoke and mirrors---only that the PRICE is.
And that is "why" the cronies talk people into buying the rumour--so they can sell the news.
The "big news" right now is that Mikey is going to a dog&pony show to convince brokers working on commission to try to push their retail cannon fodder into buying--so that BTX can keep raising the $100mm it promised to raise with the least dilution..... Not one word will be said towards any actual gross revs above G&A.
Go look and see what BTX itself says about its book value--and then decide if their estimate of the value of the patent estate is over-inflated--- my point of view---or if they are hiding the actual i/p value--which is the only thing that justifies going long over $2.
" It's going to make me some big bucks along the way." Given your entry @ ~ 4 3/8 back some time ago, it so far has done seriously worse than one of Bogle's S&P index funds.
And, thesis--shmesis.... 200 high school level words on how this dog gets to $1k gross over COG anyime in the next 4 years.....u ain;t done it, and neither has any other "long.".
As an excellent indicator of the failure to make a case for a "long" position, this post stands out. Nobody getting a margin call has fire power to knock anything anywhere.
You're half right. The human capital is on the books at wayyy over its actual productive worth. But it all makes a great chew toy for MMs, Specialists, insiders and cronies--with the only cost being to the retail cannon fodder who fall for all the hype.
"OPC trial for paralysis look promising. "..as a real estate subsidy, yes. That's wha most CIRM $$ do---support the biotech real estate sector.
The AST application to CIRM scored 72 out of a 100 as havng any benefit at all. It repeats a "failed" experiment (tha proved the injections didn't mess up anything--but did no gadd at all) with twice the dosage, and higher up the spine as a Hail Mary take on the issue.
Success??? You sounds like a "long." Note what I phrikking said: " that none of it can genedrate revs over COG any time in the next 5 years."
The essential problem here is the retail road kill confusing the "science" with the common stock. Thyere is no connectifon. To the degree there ever can be, AK, Neal, Garfies and Mikey have made dang sure it will not filter down to "buy&hold"--only be captured by traders on both sides the clear.
Nope. BTX has lots of stuff. The issue--which longs demand be ignored--is that none of it can genedrate revs over COG any time in the next 5 years. By which point necessary dilution to cover the burn will lead to negative returns for anyone with a basis over 2.
I disagree: it's a college level science project. However, there's nothing there that can get FDA approved for anything in the next two years; and even less that can generate net revs over the expended costs. Thus, more dilution to come.
The error in your analysis is thinking "they think." If they did they'd have something to say about how any of this dog's claims convert to gross revs.
dontmindthat you are a lying illiterate---
Note the word "funds"---which any 5th grader would note means baskets of positions determined by somebody else..
So, which is it? Are you stupid--or just a lying piece of #$%$ showing new readers hear that the "long" poistion is pure garbage?
Since AK made it a point to get this dog onto the ^rua and ^rut, there are a number of trades one can make that might affect this dog--even while working to avoid its inflated mkt cap like the virus that it is.
There's $50,000 waiting for anyone who can back up the claim that I have ever shorted this dog, told clients to, or retained clients who had in any possible fashion beyond writing calls on funds that held this dog.
So there, lying gameboy--if you believe a word of your own drivel, cash in.
Otherwise, just keep showing new arrivals that the "long" view on this dog consists of nothing but hype.
" the verge of medical breakthroughs," has nothing at all to do with the verge of no more dilution, and even less to do with the verge of a penny a share gross vrevs--which would still be a dilution inducing burn rate.